Performance of human chorionic gonadotropin curves in women at risk for ectopic pregnancy: exceptions to the rules  Christopher B. Morse, B.A., Mary D.

Slides:



Advertisements
Similar presentations
Clarisa R. Gracia, M. D. , M. S. C. E. , Christopher B. Morse, B. A
Advertisements

Lisa Marii Cookingham, M. D. , Rachel P. Goossen, B. A. , Amy E. T
International Committee for Monitoring Assisted Reproductive Technology (ICMART) world report: assisted reproductive technology 2003  Karl G. Nygren,
Medical management of ectopic pregnancy with single-dose and 2-dose methotrexate protocols: human chorionic gonadotropin trends and patient outcomes 
Severe maternal morbidity in ectopic pregnancy is not associated with maternal factors but may be associated with quality of care  Norah M. van Mello,
Cost-effectiveness of presumptively medically treating women at risk for ectopic pregnancy compared with first performing a dilatation and curettage 
Soyoung Bae, M.D., Joseph Karnitis, M.D.  Fertility and Sterility 
Clarisa R. Gracia, M. D. , M. S. C. E. , Christopher B. Morse, B. A
Infertility evaluation and treatment among women in the United States
No difference in cycle pregnancy rate and in cumulative live-birth rate between women with surgically treated minimal to mild endometriosis and women.
Long-term risk of ectopic pregnancy varies by method of tubal sterilization: a whole- population study  Eva Malacova, Ph.D., Anna Kemp, Ph.D., Roger Hart,
Pregnancies of unknown location after in vitro fertilization: minimally invasive management with Karman cannula aspiration  Paula Brady, M.D., Anthony.
Intrauterine injection of human chorionic gonadotropin before embryo transfer significantly improves the implantation and pregnancy rates in in vitro.
Human chorionic gonadotropin ratio of hemoperitoneum versus venous serum improves early diagnosis of ectopic pregnancy  YuDong Wang, M.D., Hong Zhao,
Cem Atabekoglu, M. D. , Murat Sonmezer, M. D. , Sinan Özkavukcu, M. D
Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study  Nicole Hope, M.B., B.S., Hon., Luk.
Isabel Cerveira, M. D. , Cristina Costa, M. D. , Fernando Santos, M. D
Comparison of fallopian tube sperm perfusion and intrauterine tuboperitoneal insemination: a prospective randomized study  Leonidas Mamas, M.D., Ph.D. 
Contribution of the rate of change of antimüllerian hormone in estimating time to menopause for late reproductive-age women  Ellen W. Freeman, Ph.D.,
Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study  Angela Kerchner, B.A., Whitney Lester,
Cutoff value of human chorionic gonadotropin in relation to the number of methotrexate cycles in the successful treatment of ectopic pregnancy  Ewa Nowak-Markwitz,
Medical treatment of ectopic pregnancy: a committee opinion
Grant D.E. McWilliams, D.O., John L. Frattarelli, M.D. 
Dendritic cells are equally distributed in intrauterine and tubal ectopic pregnancies  Birgit Kemp, Ph.D., Svenja Schmitz, M.D., Claudia A. Krusche, Ph.D.,
Application of redefined human chorionic gonadotropin curves for the diagnosis of women at risk for ectopic pregnancy  Beata E. Seeber, M.D., Mary D.
Optimizing the number of blastocyst stage embryos to transfer on day 5 or 6 in women 38 years of age and older: a Society for Assisted Reproductive Technology.
Ellen W. Freeman, Ph. D. , Clarisa R. Gracia, M. D. , Mary D
Two interesting cases of ovarian pregnancy after in vitro fertilization–embryo transfer and its successful laparoscopic management  Selvaraj Priya, M.D.,
How and when human chorionic gonadotropin curves in women with an ectopic pregnancy mimic other outcomes: differences by race and ethnicity  Katherine.
Alka Prakash, M. D. , Susan Laird, Ph. D. , Elizabeth Tuckerman, M. Sc
Establishing a human chorionic gonadotropin cutoff to guide methotrexate treatment of ectopic pregnancy: a systematic review  Seema Menon, M.D., John.
Lisa Marii Cookingham, M. D. , Rachel P. Goossen, B. A. , Amy E. T
Robert F. Casper, M.D.  Fertility and Sterility 
Association of the very early rise of human chorionic gonadotropin with adverse outcomes in singleton pregnancies after in vitro fertilization  Christopher.
Influence of acupuncture stimulation on pregnancy rates for women undergoing embryo transfer  Caroline Smith, Ph.D., Meaghan Coyle, B.Hlth.Sc. (Acup.),
Epidemiology of male and female reproductive disorders and impact on fertility regulation and population growth  Kurt T. Barnhart, M.D., M.S.C.E.  Fertility.
Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility  Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,
What are patients doing with their mosaic embryos
Beata Seeber, M. D. , M. S. C. E. , Mary D. Sammel, Sc. D
Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles  Karin.
Use of “2-dose” regimen of methotrexate to treat ectopic pregnancy
Stephanie L. F. Gustin, M. D. , Gourab Mukherjee, Valerie L. Baker, M
Marianne de Bennetot, M. D. , Benoît Rabischong, M. D. , Ph. D
Melatonin supplementation during controlled ovarian stimulation for women undergoing assisted reproductive technology: systematic review and meta-analysis.
Pete N. Lohstroh, B. S. , James W. Overstreet, M. D. , Ph. D
The forgotten coil Fertility and Sterility
Efficacy and safety of human chorionic gonadotropin for follicular phase stimulation in assisted reproduction: a systematic review and meta-analysis 
David E. Reichman, M. D. , Stacey A. Missmer, Sc. D. , Katharine F
Aviad Cohen, M. D. , Guy Bibi, M. D. , Benny Almog, M. D
Obesity does not impact implantation rates or pregnancy outcome in women attempting conception through oocyte donation  Allison Styne-Gross, M.D., Karen.
Transient abdominal ovariopexy for adhesion prevention in patients who underwent surgery for severe pelvic endometriosis  Jonathan Ouahba, M.D., Patrick.
Geographic distribution of reproductive endocrinology and infertility (REI) fellowships in the United States  Mary E. Abusief, M.D., Stacey A. Missmer,
Lindsay M. Mains, M. D. , Babak Vakili, M. D. , Yves Lacassie, M. D
Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin  Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.
Kayoko Takata, M. D. , Nobuhiko Suganuma, M. D. , Hisae Wada, M. D
Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization  David W. Schmidt, M.D.,,
Chantae Sullivan-Pyke, M. D. , Daniel J. Haisenleder, Ph. D
Impact of subclinical hypothyroidism in women with recurrent early pregnancy loss  Lia A. Bernardi, M.D., Ronald N. Cohen, M.D., Mary D. Stephenson, M.D.,
Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction and achievement of pregnancy in 154 women with.
Rachana V. Garde, M. D. , Vuk P. Jovanovic, M. D. , Grace M
Kurt T Barnhart, M. D. , M. S. C. E. , Paolo Rinaudo, M. D. , Ph. D
Genetic evaluation procedures at sperm banks in the United States
Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories  Melissa C. Yih, M.D.,
Obstructed uteri with a cervix and vagina
Progesterone level and progesterone/estradiol ratio on the day of hCG administration: detrimental cutoff levels and new treatment strategy  Eman A. Elgindy,
Briana J. Rudick, M. D. , Sue Ann Ingles, Ph. D. , Karine Chung, M. D
Ongoing pregnancy rates in intrauterine insemination are affected by late follicular- phase progesterone levels  Antonio Requena, M.D., María Cruz, Ph.D.,
Logarithmic curves depicting initial level and rise of serum beta human chorionic gonadotropin and live delivery outcomes with in vitro fertilization:
Is chromosome testing of the second miscarriage cost saving
Hyperglycosylated human chorionic gonadotropin as an early predictor of pregnancy outcomes after in vitro fertilization  Sandy Chuan, M.D., Michael Homer,
Presentation transcript:

Performance of human chorionic gonadotropin curves in women at risk for ectopic pregnancy: exceptions to the rules  Christopher B. Morse, B.A., Mary D. Sammel, Sc.D., Alka Shaunik, M.D., Lynne Allen-Taylor, Ph.D., Nicole L. Oberfoell, B.A., Peter Takacs, M.D., Ph.D., Karine Chung, M.D., M.S.C.E., Kurt T. Barnhart, M.D., M.S.C.E.  Fertility and Sterility  Volume 97, Issue 1, Pages 101-106.e2 (January 2012) DOI: 10.1016/j.fertnstert.2011.10.037 Copyright © 2012 American Society for Reproductive Medicine Terms and Conditions

Supplemental Figure 1 Cartoon of the logic of comparing actual value to that expected when following serial hCG concentrations in a women with a pregnancy of unknown location. (A) The minimal increase in hCG of 35% for intrauterine pregnancy (IUP) (blue line) and a hypothetical patient (red line) with initially appropriate, then abnormal, increase in hCG level. The “X” marks the time at which the increase is slower than anticipated and intervention may be necessary to rule out ectopic pregnancy (EP). (B) The minimal decrease in hCG for a completed miscarriage (spontaneous abortion, SAB) is depicted (blue line) and a hypothetical patient (green line) with initially appropriate, then abnormal, decrease in hCG level. The “X” marks the time at which the decline is slower than anticipated and intervention may be necessary to rule out EP. Fertility and Sterility 2012 97, 101-106.e2DOI: (10.1016/j.fertnstert.2011.10.037) Copyright © 2012 American Society for Reproductive Medicine Terms and Conditions